Price
Financials
Consolidated, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 483 | 464 | 473 | 490 | 498 | 513 | 580 | 544 | 586 | 582 | 685 | 697 |
| Expenses | 420 | 400 | 409 | 425 | 432 | 448 | 510 | 476 | 514 | 513 | 608 | 617 |
| Operating Profit | 64 | 64 | 64 | 65 | 66 | 65 | 69 | 68 | 72 | 69 | 77 | 81 |
| OPM % | 13% | 14% | 13% | 13% | 13% | 13% | 12% | 12% | 12% | 12% | 11% | 12% |
| Other Income | 1 | 4 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 20 | 4 |
| Interest | 5 | 4 | 3 | 4 | 4 | 5 | 6 | 6 | 6 | 8 | 9 | 11 |
| Depreciation | 15 | 15 | 16 | 15 | 15 | 18 | 18 | 18 | 18 | 20 | 24 | 26 |
| Profit before tax | 45 | 48 | 46 | 47 | 48 | 42 | 48 | 46 | 50 | 43 | 64 | 48 |
| Tax % | 26% | 28% | 25% | 26% | 27% | 25% | 28% | 27% | 26% | 23% | 28% | 26% |
| Net Profit | 33 | 34 | 34 | 35 | 35 | 32 | 34 | 34 | 37 | 33 | 46 | 35 |
| EPS in Rs | 5.97 | 6.23 | 6.18 | 6.32 | 6.39 | 5.73 | 6.22 | 6.07 | 6.66 | 5.92 | 8.30 | 6.34 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 516 | 600 | 709 | 1,483 | 1,656 | 1,831 | 2,080 | 2,396 | 2,550 |
| Expenses | 438 | 495 | 586 | 1,299 | 1,433 | 1,581 | 1,815 | 2,110 | 2,251 |
| Operating Profit | 78 | 105 | 124 | 184 | 223 | 250 | 265 | 286 | 299 |
| OPM % | 15% | 17% | 17% | 12% | 13% | 14% | 13% | 12% | 12% |
| Other Income | 1 | 4 | 9 | 13 | 6 | 8 | 5 | 24 | 26 |
| Interest | 3 | 4 | 3 | 13 | 22 | 19 | 18 | 29 | 34 |
| Depreciation | 12 | 17 | 23 | 48 | 63 | 60 | 67 | 79 | 87 |
| Profit before tax | 63 | 88 | 107 | 136 | 144 | 178 | 185 | 203 | 204 |
| Tax % | 28% | 26% | 25% | 28% | 26% | 26% | 26% | 26% | |
| Net Profit | 46 | 65 | 80 | 98 | 107 | 131 | 136 | 149 | 151 |
| EPS in Rs | 103.82 | 12.86 | 15.45 | 17.74 | 19.45 | 23.66 | 24.63 | 26.94 | 27.22 |
| Dividend Payout % | -0% | 4% | 3% | 3% | 3% | 2% | 2% | 2% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | 28% | 13% | 19% | ||
| Compounded Profit Growth | % | 11% | 8% | 12% | ||
| Stock Price CAGR | % | -22% | -19% | -30% | ||
| Return on Equity | % | 13% | 12% | 11% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4 | 10 | 10 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 119 | 277 | 398 | 794 | 904 | 1,037 | 1,174 | 1,322 |
| Borrowings | 8 | 67 | -0 | 8 | 74 | 119 | 218 | 436 |
| Other Liabilities | 118 | 118 | 152 | 442 | 375 | 401 | 482 | 505 |
| Total Liabilities | 250 | 471 | 561 | 1,255 | 1,364 | 1,567 | 1,886 | 2,274 |
| Fixed Assets | 74 | 94 | 181 | 607 | 585 | 578 | 598 | 784 |
| CWIP | 3 | 22 | 0 | 1 | 16 | 47 | 140 | 173 |
| Investments | -0 | 18 | -0 | 36 | 51 | 63 | 84 | 62 |
| Other Assets | 173 | 338 | 379 | 611 | 712 | 880 | 1,063 | 1,254 |
| Total Assets | 250 | 471 | 561 | 1,255 | 1,364 | 1,567 | 1,886 | 2,274 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 71 | 57 | 48 | 29 | 152 | 43 | 137 | 65 |
| Cash from Investing Activity | -37 | -190 | -37 | -299 | -181 | -103 | -183 | -220 |
| Cash from Financing Activity | -29 | 157 | -25 | 292 | 61 | 16 | 65 | 186 |
| Net Cash Flow | 5 | 23 | -14 | 22 | 32 | -44 | 19 | 31 |
| Free Cash Flow | 27 | -19 | -8 | -7 | 120 | -83 | -21 | -175 |
| CFO/OP | 118% | 74% | 64% | 43% | 89% | 39% | 74% | 47% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 57 | 74 | 75 | 78 | 85 | 83 | 85 |
| Inventory Days | 59 | 57 | 75 | 63 | 59 | 80 | 90 | 88 |
| Days Payable | 114 | 95 | 104 | 61 | 56 | 62 | 73 | 71 |
| Cash Conversion Cycle | 6 | 19 | 46 | 76 | 80 | 103 | 101 | 103 |
| Working Capital Days | 23 | 22 | 60 | 62 | 49 | 70 | 69 | 49 |
| ROCE % | 38% | 29% | 24% | 18% | 18% | 16% | 13% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 68.35% | 68.34% | 68.32% | 68.32% | 68.27% | 68.19% | 68.18% | 68.18% | 68.18% | 68.15% | 68.15% | 68.14% |
| FIIs | 5.74% | 4.14% | 4.02% | 3.83% | 3.74% | 3.74% | 3.98% | 3.48% | 2.70% | 2.32% | 2.18% | 2.03% |
| DIIs | 17.68% | 18.06% | 17.74% | 16.87% | 17.34% | 17.47% | 17.59% | 17.84% | 18.18% | 18.25% | 18.21% | 14.64% |
| Public | 8.23% | 9.45% | 9.90% | 10.98% | 10.64% | 10.60% | 10.24% | 10.50% | 10.95% | 11.25% | 11.46% | 15.19% |
| No. of Shareholders | 95,200 | 1,00,423 | 98,859 | 1,00,475 | 97,188 | 95,735 | 92,852 | 91,791 | 91,387 | 89,249 | 86,972 | 87,580 |
Fundamentals
Market Cap₹ 2,367 Cr.
Current Price₹ 428
Stock P/E15.7
Book Value₹ 241
ROCE13.3 %
ROE10.8 %
Dividend Yield0.12 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)19%
Compounded Profit Growth (TTM)12%
Consolidated figures.
Valuation
Market capRs 2,362 Cr
Enterprise valueRs 2,451 Cr
P/E (TTM)15.67x
Price to book2.25x
Price to sales0.93x
EV / EBITDA7.54x
EV / EBIT10.30x
EV / sales0.96x
Price to cash flow54.60x
Earnings yield6.38%
Dividend yield0.12%
P/E, 3-year average36.89x
P/B, 3-year average4.47x
P/E, 5-year average44.42x
P/B, 5-year average6.64x
Profitability
Operating margin (excl. other income)13.64%
Operating margin (incl. other income)14.06%
EBITDA margin12.74%
Pre-tax margin8.00%
Net profit margin5.91%
Net margin, latest quarter5.03%
ROE13.32%
ROCE18.28%
ROA8.92%
ROE, 3-year average13.96%
ROCE, 3-year average20.37%
ROA, 3-year average9.29%
ROE, 5-year average19.35%
ROCE, 5-year average25.53%
ROA, 5-year average12.30%
ROIC (approx.)15.40%
Tax rate26.42%
Other income / net worth0.73%
Growth
Sales growth (latest year)10.55%
Profit growth (latest year)21.84%
Sales CAGR, 3 years37.16%
Sales CAGR, 5 years28.81%
Profit CAGR, 3 years17.67%
Profit CAGR, 5 years23.40%
Sales growth QoQ1.80%
Profit growth QoQ-23.65%
Sales growth YoY (latest quarter)28.23%
Profit growth YoY (latest quarter)4.46%
Per share
EPS (TTM)Rs 27.28
EPS (latest year)Rs 23.66
EPS (latest quarter)Rs 6.35
EPS, 3-year averageRs 20.28
EPS, 5-year averageRs 17.83
Book value per shareRs 189.65
Sales per shareRs 461.55
Cash flow per shareRs 7.83
Free cash flow per shareRs -31.68
Dividend per share (latest year)Rs 0.50
Dividend per share, 3-year averageRs 0.50
Dividend per share, 5-year averageRs 0.50
Dividends
Dividend payout2.11%
Dividend payout, 3-year average2.50%
Dividend payout, 5-year average2.93%
Efficiency
Asset turnover1.17x
Fixed asset turnover3.17x
Inventory turnover4.97x
Inventory days73 days
Debtor days85 days
Debtors turnover4.31x
Creditor days71 days
Cash conversion cycle103 days
Working capital days49 days
Leverage
Total debtRs 119 Cr
Cash and bankRs 30 Cr
Net debtRs 89 Cr
Debt to equity0.11x
Net debt / EBITDA0.27x
Interest coverage7.04x
Current ratio (filing 2026-03-31)1.57x
Quick ratio (filing 2026-03-31)1.05x
Trade payables (filing 2026-03-31)Rs 323 Cr
Owners' fund to total sources66.85%
Debt to assets7.58%
Cash flow
Cash from Operating Activity (latest year)Rs 43 Cr
Cash from Investing Activity (latest year)Rs -103 Cr
Cash from Financing Activity (latest year)Rs 16 Cr
Net Cash Flow (latest year)Rs -44 Cr
Free cash flow (latest year)Rs -175 Cr
FCFE (approx.: FCF + change in debt)Rs -130 Cr
Cash from ops / profit, 5 years0.69x
Sales to cash flow42.32x
Statement figures
Net sales (TTM)Rs 2,550 Cr
Net sales (latest year)Rs 1,831 Cr
Sales (latest quarter)Rs 697 Cr
Operating profit excl. other income (latest year)Rs 250 Cr
Operating profit (latest quarter)Rs 81 Cr
Other income (TTM)Rs 26 Cr
EBITDA (TTM)Rs 325 Cr
PBDT (TTM)Rs 291 Cr
Profit before tax (TTM)Rs 204 Cr
Tax (latest year)Rs 47 Cr
Net profit (TTM)Rs 151 Cr
Net profit (latest year)Rs 131 Cr
Net profit (latest quarter)Rs 35 Cr
Depreciation (TTM)Rs 87 Cr
Depreciation (latest quarter)Rs 26 Cr
Interest (TTM)Rs 34 Cr
Cost of goods sold (latest year)Rs 1,404 Cr
Total expenditure (latest year)Rs 1,581 Cr
Total income (latest year)Rs 1,838 Cr
Share capitalRs 11 Cr
ReservesRs 1,037 Cr
Shareholders' fundsRs 1,048 Cr
Total assetsRs 1,567 Cr
Net blockRs 578 Cr
Capital work in progressRs 47 Cr
InvestmentsRs 63 Cr
ReceivablesRs 425 Cr
InventoryRs 282 Cr
Other liabilitiesRs 401 Cr
Shares outstanding (crore)5.52
Ownership
Promoter holding68.14% (-0.04 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/E 15.7 is at the 3th percentile of its own 5.4-year range
(median 50.9, low 15.2, high 175.5).
P/B 2.25 is at the 2th percentile (median 9.99).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | ROSSARI | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -4.2% | -2.8% | -1.5 pts |
| 1 month | -10.3% | -6.8% | -3.5 pts |
| 3 months | -18.0% | -7.6% | -10.4 pts |
| 6 months | +12.9% | +0.4% | +12.5 pts |
| 1 year | -32.4% | -9.9% | -22.5 pts |
| 2 years | -54.3% | -13.6% | -40.8 pts |
| 3 years | -47.5% | +14.2% | -61.7 pts |
| 5 years | -70.3% | +27.9% | -98.2 pts |
11 mutual fund schemes hold about ₹248 Cr.
Over three months 7 bought more and 1 sold (share counts, price move removed).
| Fund | Weight | Est. Cr | 3m shares |
|---|---|---|---|
| UTI Flexi Cap Fund | 0.34% | 82 | +7% |
| Canara Rob Small Cap Fund | 0.34% | 50 | +4% |
| Motilal Oswal Small Cap Fund | 0.35% | 29 | -25% |
| UTI Small Cap Fund | 0.53% | 28 | +8% |
| UTI Large & Mid Cap Fund | 0.29% | 19 | +7% |
| UTI Aggressive Hybrid Fund | 0.26% | 18 | +11% |
| UTI Multi Cap Fund | 0.45% | 10 | +6% |
| UTI Retirement Fund | 0.15% | 7 | +13% |
| UTI ULIP 10Y | 0.13% | 7 | +11% |
| SBI Small Cap Fund | 0.00% | 0 | |
| Motilal Oswal BSE 1000 Index Fund | 0.00% | 0 |
Red flags
F-score 5 of 8| look | Inventory outrunning sales Inventory grew 50% vs sales +11% in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹697 Cr +28.1% vs Jun 2025.
Net profit ₹35 Cr +2.9%.
Against our estimate for Jun 2026: sales +10.7%, profit -11.5% miss. Our estimate for Sep 2026: sales Rs 721 Cr, profit Rs 43 Cr (how).
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Pidilite Industries Ltd | 148,809 | 56.2 | 31.0 % |
| Gujarat Fluorochemicals Ltd | 48,402 | 78.4 | 9.64 % |
| Navin Fluorine International Ltd | 42,255 | 53.1 | 21.0 % |
| Aether Industries Ltd | 23,226 | 96.8 | 11.9 % |
| Deepak Nitrite Ltd | 20,854 | 26.3 | 11.4 % |
| Atul Ltd | 17,614 | 22.1 | 14.9 % |
| Aarti Industries Ltd | 17,045 | 32.6 | 6.86 % |
| Fine Organic Industries Ltd | 15,759 | 36.0 | 21.5 % |
| BASF India Ltd | 14,871 | 24.0 | 14.5 % |
| Privi Speciality Chemicals Ltd | 14,084 | 40.3 | 22.3 % |
| Anupam Rasayan India Ltd | 13,409 | 76.8 | 7.38 % |
| Vinati Organics Ltd | 12,173 | 24.4 | 21.4 % |
| Elantas Beck India Ltd | 10,820 | 60.9 | 21.2 % |
| Jubilant Ingrevia Ltd | 10,180 | 32.0 | 11.4 % |
| Alkyl Amines Chemicals Ltd | 9,111 | 40.5 | 16.6 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2026-07-10 | Dividend - Rs 0.50 Per Share | |
| 2025-06-20 | Dividend - Re 0.50 Per Share | |
| 2024-11-04 | Extra Ordinary General Meeting | |
| 2024-08-16 | Annual General Meeting/Dividend - Re 0.50 Per Share | |
| 2023-05-24 | Annual General Meeting/Dividend - Re 0.50 Per Share | |
| 2022-07-07 | Annual General Meeting/Dividend - Rs 0.50 Per Share | |
| 2021-09-08 | Annual General Meeting/Dividend - Rs 0.50 Per Share |
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Rossari Biotech Ltd?
Rossari Biotech Ltd (ROSSARI) has a market capitalisation of Rs 2,367 Cr. at the 2026-10-01 close.
What is the P/E ratio of Rossari Biotech Ltd?
Rossari Biotech Ltd trades at a P/E of 15.7 on trailing twelve-month profit, at the 2026-10-01 close.
What were Rossari Biotech Ltd's latest quarterly results?
In the Jun 2026 quarter, Rossari Biotech Ltd sales was Rs 697 Cr (+28.1% vs Jun 2025) and net profit was Rs 35 Cr.
What is the 52-week high and low of Rossari Biotech Ltd?
The 52-week high is Rs 690.30 and the 52-week low is Rs 375.00.